Literature DB >> 3287982

Validity of self-report in alcoholism research: results of a Veterans Administration Cooperative Study.

R K Fuller1, K K Lee, E Gordis.   

Abstract

The validity of self-report in alcoholism treatment research is controversial. Our recently completed Veterans Administration Cooperative Study evaluating the efficacy of disulfiram treatment for alcoholism provided an opportunity to assess the validity of self-report. To assess treatment response, patients and household contacts were interviewed at seven scheduled points during the 1 year of follow-up. Blood specimens also were obtained from the patients at these times and were analyzed for ethanol. Eighty-eight percent of the patient and/or collateral interviews were obtained at 6 months and 90% at 1 year. The mean number of blood and urine specimens collected per patient was 4.3 and 14.4, respectively. Outcome criteria included continuous abstinence during the year and total number of drinking days. Continuous abstinence: If we had had only the patients' self reports, we would have significantly underestimated the percentage of men who drank. By self-report 58.7% (355/605) relapsed whereas the combination of self report, collaterals' reports, and laboratory tests indicated that 72.4% (438/605) drank (p less than 0.001). Using Bayes' theorem, the conditional probability that a patient is continuously abstinent for 1 year when he so claims is 65%. Total drinking days: Of the 213 patient-collateral pairs each of whom provided all seven scheduled interviews, 46.9% (100/213) agreed on the total number of drinking days during the year.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3287982     DOI: 10.1111/j.1530-0277.1988.tb00180.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  13 in total

1.  Mental health, drug use, and the transition from welfare to work.

Authors:  Isaac D Montoya; David C Bell; John S Atkinson; Carl W Nagy; Donna D Whitsett
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

2.  Future prospects for biomarkers of alcohol consumption and alcohol-induced disorders.

Authors:  Willard M Freeman; Kent E Vrana
Journal:  Alcohol Clin Exp Res       Date:  2010-04-05       Impact factor: 3.455

Review 3.  Circulating cytokines as biomarkers of alcohol abuse and alcoholism.

Authors:  Rajeshwara N Achur; Willard M Freeman; Kent E Vrana
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

4.  Suicidal ideation and attempted suicide among women living with HIV/AIDS.

Authors:  Nina A Cooperman; Jane M Simoni
Journal:  J Behav Med       Date:  2005-04

5.  Moderate alcohol consumption and loss of cerebellar Purkinje cells.

Authors:  P J Karhunen; T Erkinjuntti; P Laippala
Journal:  BMJ       Date:  1994-06-25

6.  Capture-recapture methods to size alcohol related problems in a population.

Authors:  G Corrao; V Bagnardi; G Vittadini; S Favilli
Journal:  J Epidemiol Community Health       Date:  2000-08       Impact factor: 3.710

Review 7.  Candidates for liver transplantation with alcoholic liver disease: Psychosocial aspects.

Authors:  Diogo Telles-Correia; Inês Mega
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 8.  Protein biomarkers of alcohol abuse.

Authors:  Mariana P Torrente; Willard M Freeman; Kent E Vrana
Journal:  Expert Rev Proteomics       Date:  2012-08       Impact factor: 3.940

Review 9.  Alcohol use and congestive heart failure: incidence, importance, and approaches to improved history taking.

Authors:  Christine E Skotzko; Alina Vrinceanu; Lynnette Krueger; Ronald Freudenberger
Journal:  Heart Fail Rev       Date:  2007-11-22       Impact factor: 4.214

10.  Usefulness of Gamma Glutamyl Transferase as Reliable Biological Marker in Objective Corroboration of Relapse in Alcohol Dependent Patients.

Authors:  Siddharth Dixit; Parduman Singh
Journal:  J Clin Diagn Res       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.